Biotech News
Medicovestor Signs Strategic Partnership with Sanyou Biopharmaceuticals to Advance Chemoimmunotherapy ADCs
Medicovestor, a biotechnology company based in New York, has entered into a strategic partnership with Sanyou Biopharmaceuticals, a Shanghai-based biologics specialist. The partnership, signed on 6 June, aims to jointly develop first-in-class chemoimmunotherapy antibody-drug conjugates (ADCs) targeting cancer and autoimmune diseases.
11 June 2025